POMDOCTOR to End ADR Program and Consolidate Shares
POMDOCTOR will terminate its ADR program before the market opens on Oct. 21, 2026, and list Class A ordinary shares on Nasdaq. Each 10 ADSs will become 3 post-consolidation Class A shares.
POMDOCTOR will terminate its ADR program before the market opens on Oct. 21, 2026, and list Class A ordinary shares on Nasdaq. Each 10 ADSs will become 3 post-consolidation Class A shares.